HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 102.72
(-1.37%)
CNY 102.72
(-1.37%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.03 Million CNY | -89.41% |
| 2022 | 9.74 Million CNY | 82.21% |
| 2021 | 5.34 Million CNY | -77.7% |
| 2020 | 23.98 Million CNY | 377.28% |
| 2019 | 5.02 Million CNY | -16.61% |
| 2018 | 6.02 Million CNY | -13.71% |
| 2017 | 6.98 Million CNY | -11.52% |
| 2016 | 7.89 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 10 Million CNY | 0.0% |
| 2024 Q1 | 789.75 Thousand CNY | 0.0% |
| 2024 Q2 | 930.89 Thousand CNY | 0.0% |
| 2023 Q3 | 7.16 Million CNY | -4.98% |
| 2023 FY | 1.03 Million CNY | -89.41% |
| 2023 Q1 | 8.55 Million CNY | -12.22% |
| 2023 Q4 | 1.03 Million CNY | -85.59% |
| 2023 Q2 | 7.53 Million CNY | -11.88% |
| 2022 Q4 | 9.74 Million CNY | 470.75% |
| 2022 Q3 | 1.7 Million CNY | -28.37% |
| 2022 Q2 | 2.38 Million CNY | -75.27% |
| 2022 Q1 | 9.63 Million CNY | 80.22% |
| 2022 FY | 9.74 Million CNY | 82.21% |
| 2021 Q1 | 11.44 Million CNY | -52.3% |
| 2021 Q2 | 7.06 Million CNY | -38.23% |
| 2021 FY | 5.34 Million CNY | -77.7% |
| 2021 Q4 | 5.34 Million CNY | -35.55% |
| 2021 Q3 | 8.29 Million CNY | 17.41% |
| 2020 FY | 23.98 Million CNY | 377.28% |
| 2020 Q4 | 23.98 Million CNY | 466.62% |
| 2020 Q3 | 4.23 Million CNY | -5.94% |
| 2020 Q2 | 4.49 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q4 | 5.02 Million CNY | 0.0% |
| 2019 FY | 5.02 Million CNY | -16.61% |
| 2018 FY | 6.02 Million CNY | -13.71% |
| 2017 FY | 6.98 Million CNY | -11.52% |
| 2016 FY | 7.89 Million CNY | 0.0% |